Long-term treatment with Des-Phe-Insulin
Hirn, S.; Pietschmann, H.
Wiener Klinische Wochenschrift 94(24): 662-665
1982
ISSN/ISBN: 0043-5325 PMID: 6820587 Document Number: 182707
At a geriatric department 61 insulin-dependent diabetics have been treated with des-phe-insulin (DPI) for periods of up to 6 years since 1976. The use of either pure DPI, amorphous DPI or DPI mixed with varying amounts of crystalline non-modified insulin of the same species allowed flexible longterm therapy, as well as management of metabolic emergencies. Comparison of the doses needed before and after change to and from other insulin preparations showed no difference in efficacy. No side effects of such severity as to necessitate interruption of therapy were observed.
Document emailed within 1 workday
Related Documents
Jensen, M.K.; Ditzel, J.; Lervang, H.H.; Jensen, S.; Pedersen, J.O. 1993: Short-term and long-term effects on glycosylated hemoglobin after transition from conventional insulin treatment to multiple insulin injection regime in a diabetic outpatient clinic Ugeskrift for Laeger 155(44): 3567-3571Piers, D.A.; Sluiter, W.J.; Reitsma, W.D.; Doorenbos, H. 1974: Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin Netherlands Journal of Medicine 17(4-5): 234-238
Van Ballegooie, E.; Reitsma, W.D.; Sluiter, W.J.; Doorenbos, H. 1984: Feasibility and efficacy of long-term treatment by continuous subcutaneous insulin infusion (CSII) in insulin-dependent diabetes Netherlands Journal of Medicine 27(5): 185-192
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Skrha, F.; Stríteský, J.; Fábryová, D.; Josífko, M. 1977: Eye changes in diabetics after long-term treatment with insulin Vnitrni Lekarstvi 23(11): 1066-1071
Lepore, G.; Dodesini, A.R.; Nosari, I.; Trevisan, R. 2004: Effect of continuous subcutaneous insulin infusion vs multiple daily insulin injection with glargine as basal insulin: an open parallel long-term study Diabetes Nutrition and Metabolism 17(2): 84-89
Dvoráková, L.; Svoboda, Z.; Hirs, P.; Platilová, H.; Blahos, J.; Kmoch, J.; Hájková, E.; Slezák, Z.; Porsová, I. 1985: Long-term treatment with in insulin infusion pump in a juvenile diabetic complicated by thyrotoxicosis and strumectomy Casopis Lekaru Ceskych 124(7): 218-220
Seriolo, B.; Paolino, S.; Ferrone, C.; Cutolo, M. 2008: Impact of long-term anti-TNF-alpha treatment on insulin resistance in patients with rheumatoid arthritis Clinical and Experimental Rheumatology 26(1): 159-60; author reply 160
Fujii, S.; Kaku, K.; Andou, S.; Nakayama, H.; Suetsugu, N.; Inoue, M.; Yoshizaki, Y.; Matsuda, M.; Tanaka, M.; Okafuji, S. 1993: Glucose and lipid metabolism during long-term antihypertensive treatment with indapamide in non-insulin-dependent diabetic patients Clinical Therapeutics 15(6): 1041-1050
Jungmann, E.; Helling, T.; Jungmann, G.; Mertens, C.; Snelting, U. 2001: Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria Fortschritte der Medizin. Originalien 118(4): 141-146
Shimoda, S.; Nishida, K.; Sakakida, M.; Konno, Y.; Ichinose, K.; Uehara, M.; Nowak, T.; Shichiri, M. 1997: Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas Frontiers of Medical and Biological Engineering: the International Journal of the Japan Society of Medical Electronics and Biological Engineering 8(3): 197-211
Boratyńska, M.; Boratyński, J.; Magott, M.; Szewczyk, Z. 1996: The effect of long term erythropoietin treatment on levels of free amino acids in patients with long term hemodialysis Przeglad Lekarski 53(5): 398-401
Alonso López, F.A.; Anzola Fernández, B.; Arratibel Arrondo, J.; Gancedo González, Z. 1993: Who prescribes? Origin and adequacy of long term prescriptions included in a computerized long term treatment programme at a health center Atencion Primaria 12(8): 465-468
Satirapoj, B.; Leelasiri, K.; Supasyndh, O.; Choovichian, P. 2014: Short-term administration of an angiotensin Ii receptor blocker in patients with long-term hemodialysis patients improves insulin resistance Journal of the Medical Association of Thailand 97(6): 574-581
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Adamíková, A.; Rybka, J. 2014: Long-term acting insulin analogues and the risks of hypoglycemic incidence Vnitrni Lekarstvi 60(9): 680-683
Teuscher, A.U.; Seaquist, E.R.; Pittelkow, M.R.; Robertson, R.P. 1994: The effect of long-term cyclosporin and prednisone therapy on insulin secretory reserve Schweizerische Medizinische Wochenschrift 124(45): 2036-2038
Beck, A.; Baumung, H.; Caucig, H.; Golob, E. 1973: The influence of long-term oral contraception on blood sugar and serum insulin Geburtshilfe und Frauenheilkunde 33(8): 647-652
Natarajan, R.; Kathuria, S.; Lanting, L.; Gonzales, N.; Nadler, J. 1995: Differential short- and long-term effects of insulin on ANG II action in human adrenal glomerulosa cells American Journal of Physiology 268(1 Pt 1): E100-E106
Popov, S.V.; Chekhov, A.M.; Pekarskiĭ, V.V.; Gimrikh, E.O.; Savenkov, G.G. 1988: Long-term treatment of ventricular arrhythmia caused by electrocardiographic long QT syndrome Kardiologiia 28(7): 92-95